Cancer Clinical Trial -AtlasMedx, Incorporated-AMXI-5001

Cancer

Status:

Open

ClinicalTrials.gov:

NCT04503265

A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies

Drug

AMXI-5001

Phase

Phase II

Condition

Advanced Solid Tumors

Keywords

BRCA, PARP Inhibitor, Microtubule inhibitor